Hikma Pharmaceuticals (OTCMKTS:HKMPF) Sets New 12-Month High – Here’s What Happened

Posted by Joseph Casey on Feb 24th, 2025

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $28.92 and last traded at $28.92, with a volume of 8632 shares changing hands. The stock had previously closed at $28.14.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada raised Hikma Pharmaceuticals from a “hold” rating to a “moderate buy” rating in a research note on Tuesday, December 10th.

Read Our Latest Report on HKMPF

Hikma Pharmaceuticals Stock Up 2.7 %

The company’s 50 day moving average price is $25.71 and its two-hundred day moving average price is $25.29. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.98 and a current ratio of 1.66.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.